Skip to main content
Premium Trial:

Request an Annual Quote

Data Sharing Works

Seven years ago, NIH, FDA, researchers from industry, academia, and some nonprofit groups got together to find biomarkers for Alzheimer's disease. Now, the New York Times' Gina Kolata says the collaboration has resulted in several papers on early diagnosis of Alzheimer's using PET scans and spinal fluid tests, and more than 100 drug studies in progress. The key to the project, Kolata says, is the data sharing aspect. The data the researchers gathered was free to anyone who wanted it. "No one would own the data. No one could submit patent applications, though private companies would ultimately profit from any drugs or imaging tests developed as a result of the effort," she writes. Though the researchers worried at first about how their data would be used, they realized they had no choice but to collaborate with as many people as possible in order to get any results. The collaboration is already serving as a model for similar efforts against Parkinson's disease, Kolata writes.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.